Background: Most of the asthma susceptibility genes have demonstrated moderate effect. Gene-gene interaction may play a role in asthma.
Introduction
Airway structural changes or remodeling occurred in adults and children with asthma. 1 In most asthma phenotypes, chronic airway inflammation plays a causal role in airway remodeling. However, airway remodeling was reported in some young children who subsequently developed asthma, which suggests that remodeling can occur early in the disease course. 2 Although inhaled corticosteroid, which is the mainstay of asthma treatment, provides asthma control and reduces airway hyperresponsiveness, it does not affect the natural course of the disease or the decline in lung function. 3 Improved understanding of the mechanisms of the remodeling process may yield other therapeutic targets that could potentially change the natural course of the disease.
Given the structural components of airway remodeling, factors of interest should include those involving tissue fibrosis, angiogenesis, and the repair process. The genes identified as having a role in these processes include a disintegrin and metalloprotease 33 (ADAM33), transforming growth factor β1 (TGFβ1), vascular endothelial growth factor (VEGFA), and urokinase plasminogen activator receptor (PLAUR). Ito, et al. investigated ADAM33 expression in airway smooth muscle (ASM) cells, and found ADAM33 mRNA and protein expression to be significantly higher in asthmatic subjects than in controls. 4 Genetic research by positional cloning method revealed the ADAM33 gene to be significantly associated with the prevalence of asthma and airway hyperresponsiveness. 5 Thongngarm, et al. found single nucleotide polymorphisms (SNPs) and haplotypes of ADAM33 to be associated with not only the prevalence, but also the severity of asthma in Thai population. 6 ADAM33 SNPs were also found to be associated with decline in lung function and airway remodeling. 7 Evidence was reported that the ADAM33 gene teamed up with other genes (i.e., TGFβ1, VEGFA, and PLAUR), which affected the proteolytic pathway and resulted in airway remodeling. 8 TGFβ1 expressed on inflammatory cells in submucosal and smooth muscle cell layers in the airways is associated with the severity of asthma. 9 TGFβ1 SNPs were shown to be associated with asthma and its severity in many different ethnic populations. 10 VEGFA enhances ADAM33 expression and ASM cell proliferation by activating the VEGFR2/ERK1/2 signaling pathway, which might involve in the pathogenesis of airway remodeling. 11 Inhibition of VEGF, which increased in the lung tissues and sputum of asthmatic patients, significantly reduced goblet cell hyperplasia and basement membrane thickness. 12 PLAUR activation is mediated by ADAM proteins, which suggests that there might be a functional relationship underlying the association between ADAM33 and PLAUR. 13 PLAUR mediating VEGF-induced migration of vascular endothelial cells was also reported. 14 Previous studies identified an association between multiple PLAUR SNPs and asthma, decline in FEV 1 , and PLAUR serum levels. 15 Most of the asthma susceptibility genes identified thus far have demonstrated only moderate effect, and the results are sometimes poorly replicated. Gene-gene interaction, which is defined as the phenotypic effect of a variant at one genetic locus depending on variants at other loci, as opposed to single genetic variant, may play a role in complex genetic diseases like asthma. Given the close relationship and overlapping functions among these four genes and asthma, we aimed to investigate: 1) the genetic effects of SNPs in the ADAM33, TGFβ1, VEGFA, and PLAUR genes on asthma susceptibility, and 2) the effect of gene-gene interactions among these genes on asthma in Thai pediatric and adult population. Bangkok, Thailand. Asthma was diagnosed based on symptoms and spirometry assessments using criteria outlined by the American Thoracic Society. Degree of asthma severity was determined according to guidelines provided by the Global Initiative for Asthma. Asthmatic subjects were subcategorized into the low-severity group (n = 106) and the high-severity group (n = 144). Control subjects were asymptomatic for asthma and were devoid of atopic or pulmonary diseases. Pregnant or lactating female subjects were excluded. This study was conducted in accordance with the principles set forth in the Declaration of Helsinki and all of its subsequent amendments. The protocol for this study was approved by the institutional review board (IRB) of both participating centers, and written informed consent was obtained from all enrolled subjects.
Polymorphism genotyping
As the four genes (TGFβ1, VEGFA, PLAUR and ADAM33) with overlapping functions have a close relationship with asthma via airway remodeling involving tissue fibrosis, angiogenesis, and the repair process. We thus hypothesized that they are associated with the development of asthma and gene interactions among them may be possible. In the present study, we selected 11 SNPs from them to verify the hypothesis in Thai population.
All the three SNPs in ADAM33 gene (rs528557/S2, rs598418 and rs44707/ST+4) were selected because they have been identified as validated SNPs from our previous study. (6) The other eight SNPs including the two in TGFβ1 (rs2241715 and rs11466345), two in VEGFA (rs833069 and rs3025010), and four in PLAUR (rs344781, rs344787, rs2239374 and rs2239372) were chosen based on their validation status, minor allele frequency (MAF) higher than 0.2 and heterozygosity between 0.4-0.5 using the data from Pan-Asian SNP (http:// www4a.biotec.or.th/PASNP), Tag SNP (https://www.genome. gov/10001688/international-hapmap-project), SNPedia (https: //www.snpedia.com/index.php/SNPedia) and ThaiSNP2 database (http://www4a.biotec.or.th/thaisnp2/). These eight SNPs are haplotype-tagging SNPs regarding haplotype structures in Thai population.
Blood samples were collected in EDTA-containing tubes. Genomic DNA was extracted and used as a template. Eleven SNPs in four genes were genotyped in this study, as described in Table 1 .
Three sets of multiplex polymerase chain reaction (multiplex PCR) were performed, using newly designed primers by Oligo 6 Primer Analysis Software (Molecular Biology Insights, Inc., Colorado Springs, CO, USA). Each multiplex PCR set was amplified in 25 µL reaction volume containing 1x Immobuffer, 3.0 mM MgCl 2 , 1.0 mM dNTPs (Promega Corporation, Madison, WI, USA), 10 pmol of each primer, 1.0 U Immo-lase™ DNA Polymerase (Bioline, London, United Kingdom), and 50 ng of genomic DNA. The PCR condition consisted of predenaturation at 95°C for 15 min, followed by 40 cycles of denaturation at 95°C for 30 s, annealing at the optimal melting temperature for 30 s, extension at 65°C for 2 min, and then final extension at 65°C for 10 min on a Mastercycler® Pro S PCR system (Eppendorf, Hamburg, Germany). Multiplex PCR products were cleaned up using Exo-SAP-IT® PCR
Methods

Subjects
Two hundred and fifty each of asthmatic and control Thai subjects were recruited from pediatric and adult allergy and immunology clinics from two tertiary care centers located in 
Sample size calculation
After the single-locus analysis was performed, the number of samples required to detect genetic association was calculated using a Power for Genetic Association Analyses (PGA) package. 16 This process was performed to ensure that this study has sufficient statistical power to identify significant associations, without the risk of identifying false-positive associations (β = 0.2).
Linkage disequilibrium analysis
Linkage disequilibrium between loci in or near the same gene was measured and described as D′ and r 2 . Linkage disequilibrium is an indicator for deciding whether the association result is influenced by a haplotype effect. 17 A Java LINkage disequilibrium plotter (JLIN) was used to display D′ and r 2 . 18
Multi-locus analysis
Statistical epistasis was detected using a multifactor dimensionality reduction (MDR) technique. 19 Statistical epistasis detection was performed to increase the possibility of detecting susceptibility loci. 20 
CDX = Chinese Dai in Xishuangbanna, China; KHV = Kinh in Ho Chi Minh City, Vietnam
Product Cleanup Reagent (Affymetrix, Santa Clara, CA, USA). The purified PCR products were used as templates for genotyping using the single-base extension (SBE) method.
Each set of SBE product was directly detected by a fully -denaturing mode of denaturing high-performance liquid chromatography (DHPLC) using a WAVE™ Nucleic Acid Fragment Analysis System equipped with an OLIGOSep™ cartridge (Transgenomic, Inc., Omaha, NE, USA). The elution profile of each SNP was confirmed by direct DNA sequencing.
Direct DNA sequencing was performed using a BigDye® Terminator v3.1 Cycle Sequencing Kit (Thermo Fisher Scientific, Inc., Waltham, MA, USA). The sequencing reaction was prepared in 10 µL volume consisting of 1 µL of BigDye® Terminator v3.1 Solution, 6.4 pmol of primer, and 30 ng of PCR product, which was subjected to predenaturation at 96°C for 1 min followed by 35 cycles of denaturation at 96°C for 1 min, annealing 50°C for 10 s, and extension at 60°C for 4 min on a Mastercycler® Pro S PCR system (Eppendorf).
Statistical analysis Single-locus analysis
The genotype distribution of each SNP within the control, case, low-severity, high-severity, combined case-control, combined low-severity-control, and combined high-severity-control groups was tested for departure from Hardy-Weinberg equilibrium using χ 2 test (α = 0.05). Association between each SNP and the disease or the severity level was determined by
Haplotype association and interaction analysis
In addition to the genetic association analysis that uses genotype information, analysis that uses haplotype information was also performed. Haplotypes were inferred from every combination of SNPs in or near the same gene. All configurations of haplotypes and combinations of haplotypes from different genes were analyzed for possible association with the disease or severity level. The consideration of haplotype combinations facilitates the detection of haplotype interaction. The selected configuration of haplotypes or haplotype combinations for association explanation was the one with the lowest unadjusted p-value obtained through a permutation test. If two or more configurations had the lowest unadjusted p-value, then the most parsimonious configuration, the configuration with the least number of SNPs, was the one selected. The global null hypothesis that none of configurations of haplotypes and haplotype combinations is associated with the disease or severity
Results
Clinical characteristics of high and low severity groups are shown in Table 2 . Subjects in the high severity group were significantly older and suffered from asthma for longer duration than those in the low severity group. The mean FEV 1 was significantly lower in the high severity group as compared to those of the low severity group. Allele frequencies of eleven SNPs in four genes including TGFβ1, VEFGA, PLAUR and ADAM33 are shown in Table 3 .
Single-locus analysis
The genotype distribution calculated by using χ 2 test of two SNPs, the TGFβ1 rs2241715 and PLAUR rs344787, in the control group departed from Hardy-Weinberg equilibrium. Promoter level was also tested. Haplotype association and interaction analysis was performed using FAMHAP software. 21 As a result, these two SNPs were excluded from further association analysis. As a result of the departure from Hardy-Weinberg equilibrium, a multiplicative model was not considered in the case-control association analysis of the ADAM33 rs528557/S2 SNP, in the low-severity group-control association analysis of the VEGFA rs833069 SNP and ADAM33 rs528557/ S2 SNP, and in the high-severity group-control association analysis of VEGFA rs3025010 SNP. 22 The ADAM33 rs528557/ S2 SNP was found to be associated with asthma according to the additive and dominant models. In addition, the VEGFA rs833069 SNP was associated with the low-severity group of disease according to a recessive model, while the ADAM33 rs528557/S2 SNP was also associated with the low-severity group of disease according to the additive and dominant models. No SNPs were associated with the high-severity group of asthma. Therefore, no further association analysis involving the high-severity group was performed. The association results are summarized in Table 4 .
Sample size
Dejsomritrutai, et al. reported a prevalence of asthma in Thailand of 2.91%. 23 With the availability of prevalence, it is possible to estimate the penetrance of each SNP genotype that is associated with asthma or asthma severity level. As a result, the required number of samples for association studies can be calculated. The minimum required number of balanced case-control samples was calculated to be 468; so, the number of case-control samples in this study was sufficient. The minimum required numbers of low-severity samples and control samples based on the detected association at the VEGFA rs833069 SNP were 103 and 242, respectively; as such, these numbers of samples were also sufficient. In contrast, the required minimum numbers of low-severity samples and control samples based on the detected association at the ADAM33 rs528557/S2 SNP were 115 and 270, respectively. These minimum required numbers exceeded the numbers of low-severity samples and control samples in this study. Therefore, it cannot be definitely concluded that ADAM33 rs528557/S2 SNP was associated with the low-severity group of disease.
Linkage disequilibrium
Seven SNPs shown in Figure 1 exhibited pairwise linkage disequilibrium. These SNPs can be divided into three groups of linked SNPs according to their locations in the genome. The first group consisted of the VEGFA rs833069 and rs3025010 SNPs. The second group consisted of the PLAUR rs344787 SNP, and the rs344781 SNP located near PLAUR. The third group consisted of the ADAM33 rs44707/ST+4, rs598418, and rs528557/S2 SNPs. Haplotype association and interaction analysis was, therefore, deemed appropriate.
Multi-locus analysis
MDR selected the ADAM33 rs528557/S2 SNP as the most informative SNP for both case-control and low-severity group-control classification. Nonetheless, a permutation test with 1,000 randomized replicates revealed that the null hypothesis of no association cannot be rejected in either setting (p > 0.05). As a result, multi-locus analysis did not provide additional information regarding genetic association.
Haplotype association and interaction analysis
Haplotype association and interaction analysis revealed two sets of SNP pair to be associated with asthma. Both sets of SNP pair had the lowest unadjusted p-values (p < 0.0001) and contained the least number of SNPs. The first set consisted of the ADAM33 rs528557/S2 and rs598418 SNPs, while the second set consisted of the ADAM33 rs528557/S2 and rs44707/ ST+4 SNPs. All three SNPs were in linkage disequilibrium, and all three are in ADAM33. No haplotype interactions were detected in the case-control analysis. These results are summarized in Table 5A . Haplotype association and interaction analysis also revealed ADAM33 rs528557/S2 SNP to be associated with low-severity asthma (unadjusted p < 0.0001), and no haplotype interactions were detected in the low-severity group-control analysis. These results are given in Table 5B . However, since the sample size calculation required a higher number of samples than the number of samples that we had in this study for detecting association between ADAM33 rs528557/S2 SNP and low-severity group, a conclusion regarding the aforementioned low-severity group-control association cannot be conclusively established. 
Discussion
Gene segments covering 11 SNPs in four genes, including ADAM33, TGFβ1, VEGFA, and PLAUR, were amplified. Single locus analysis revealed the ADAM33 rs528557/S2 SNP and VEGFA rs833069 SNP to be associated with asthma susceptibility. The ADAM33 rs528557/S2 SNP exhibited significant association with asthma compared to controls in both additive and dominant model (p = 0.00468 and p = 0.01197, respectively). This ADAM33 rs528557/S2 SNP was previously shown to be associated with asthma in Thai population, 6 as well as in other populations worldwide. 24 We also identified the VEGFA rs833069 SNP as being significantly associated with low-severity asthmatics compared to controls in recessive model (p = 0.03420). The frequency of haplotype CC at the ADAM33 rs528557/S2 and rs598418 SNPs of asthmatic subjects was significantly lower than that of controls (odds ratio [OR]: 0.1, 95% confidence interval [CI]: 0.03-0.3). At ADAM33 rs528557/S2 and rs44707/ST+4 SNPs, a significantly higher frequency of haplotype GA in asthmatic subjects was observed (OR: 1.62, 95% CI: 1.23-2.14); whereas, haplotype CA was shown to be a protective variant (OR: 0.56, 95% CI: 0.38-0.83). No gene-gene interactions were observed in this study.
Over the last 15 years, the effect of the ADAM33 gene on asthma has been replicated in different populations worldwide, particularly in Asian population. Previous studies in adult and pediatric Indian population found the ADAM33 rs528557/ S2 and rs44707/ST+4 SNPs to associate with asthma and its severity. 25 Regarding association studies, some positive results might not be replicated possibly due to a small sample size and/or the heterogeneity of samples. Therefore, meta-analyses might be better for identifying causative polymorphisms with better consistency, and this would result in accurate analysis of genetic risks. Two large meta-analyses investigated ADAM33 polymorphisms, particularly the rs528557/S2 and rs44707/ST +4 SNPs. Song, et al. recruited 13 studies (4,942 asthmatics and 7,933 controls) in five ADAM33 SNPs, and found that ADAM33 rs528557/S2 SNP conferred susceptibility to asthma in European population, whereas ADAM33 rs44707/ST+4 did so in Asian population. 26 Tripathi, et al. reviewed 13 studies (3,270 asthmatics and 2,922 controls) in 12 ADAM33 SNPs, and found rs597980/ST+5, rs528557/S2 and rs2280091/T1 SNPs to be associated with asthma with an odds ratio ranging from 1.67-4.34. 27 A recent meta-analysis of eight studies found ADAM33 rs2280091/T1, rs2280090/T2, rs2787094/V4, rs44707/ST+4, and rs528557/S2 SNPs to be significantly associated with a high risk of childhood asthma. 28 However, different variants, including the rs2280091/T1, rs2787094/V4, rs511898/ F+1, rs2280090/T2, and rs2280089/T+1 polymorphisms on 14 ADAM33 SNPs, identified in a huge meta-analysis were significantly associated with asthma, especially in Asian population. 29 As a result of the expression of ADAM33 on airway epithelium, fibroblasts, myofibroblasts, and smooth muscle cells, it was postulated that ADAM33 possibly associates with airway responsiveness and remodeling, although the exact mechanism remains unknown. Of interest, airway remodeling was reported to be reversible after inhibiting human soluble ADAM33, which was found to increase in the airways and cause remodeling independent of inflammation. 30 Genetic variants of VEGFA have only rarely been reported as an asthma susceptibility gene, especially in Asian population. To our knowledge, the only study in Asia was performed in Chinese Han population, and that study found significant association between the VEGFA rs3025020 and rs3025039 SNPs and asthma compared to controls. 31 A previous study that analyzed 10 VEGFA SNPs found the rs833058 to be associated with asthma and increased airway responsiveness. 32 In addition, the VEGFA rs4711750 SNP and its haplotype were found to be associated with FEV 1 /FVC and decline in pulmonary function. 32 VEGFA SNPs demonstrated association with lung function parameters in childhood independent of asthma. 33 This supports the results of a previous study that showed that airway inflammation and remodeling can occur in parallel. 34 The effect of the VEGFA gene on lung function parameters, independent of the degree of inflammation, may explain why we found significant association between the VEGFA SNP and the low-severity asthma group, but not the high-severity asthma group.
Regarding the observed associations between the ADAM33 rs528557/S2 SNP with asthma according to the additive and dominant models, the SNP (NM_025220.4:c.2151G>C, p.G717=) is merely a silent variant which does not cause an amino acid substitution. While the VEGFA rs833069 SNP (NM_003376.5:c.658+450T>C) which was significantly associated with the low-severity asthma group compared with the controls is only a deep intronic variant. Its effect is thus not directly related to the protein structural change. However, the two non-coding SNPs possibly induce aberrant splicing or only being in linkage disequilibrium (LD) with the actual functional SNPs elsewhere on the same chromosome. Furthermore, the functional consequences of both SNPs as expression quantitative trait loci (eQTL) influencing the abundance of specific transcripts would be also possible. 35 For biological link between these SNPs and asthma, we postulate that airway epithelial injury by allergens and irritants together with these SNPs induces inflammatory cytokine release leading to activation of dendritic cells, T-helper cell type 2 and innate lymphoid cell type 2 which causes aberrant expression of mRNA and protein expression in mesenchymal cells, ASM cells and fibroblasts. However, the exact role of these SNPs in asthma pathogenesis and severity remain to be elucidated.
This study has some limitations. First, allele frequencies may be altered by different environmental factors that interact with the selected genetic variants. Second and last, the modest size of our study population may have given our study insufficient statistical power to detect interactions between SNPs with low minor allele frequencies.
In conclusions, the results of this study revealed the ADAM33 rs528557/S2 SNP and VEGFA rs833069 SNP to be associated with Thai pediatric and adult asthma, as well as with other populations worldwide. No gene-gene interactions were observed in this study. Further studies are warranted to investigate the use these SNPs as biomarkers for establishing early diagnosis or for predicting future risk of asthma.
